Loading...

COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

Inhalation Anesthesia Market by Product (Sevoflurane, Desflurane, Isoflurane, and Nitrous Oxide), Application (Induction and Maintenance), and End-User (Hospitals and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2019–2026

A06080
Pages: 165
Mar 2020 | 536 Views
 
Author(s) : Kavita Joshi , Onkar Sumant
Tables: 110
Charts: 28
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Inhalation Anesthesia Market

Request Now !

The global inhalation anesthesia market was valued at $1,137 million in 2018 and is expected to reach $1,549 million by 2026, registering a CAGR of 4.2% from 2019 to 2026. Anesthetic agents are used during surgical procedures to control pain, breathing, blood pressure, blood flow, and heart rate & rhythm. Inhalational anesthesia is primarily used for the induction of general anesthesia and sedation purposes. The most widely used inhalational anesthetics are sevoflurane, desflurane, and nitrous oxide. Inhalational anesthetics usually result in respiratory depression, reduction in arterial blood pressure and cerebral metabolic demand, and rise in cerebral blood flow. The most common side effect of inhalation anesthesia is nausea. 

Inhalation Anesthesia Market

Get more information on this report : Request Sample Pages

Significant rise in the number of emergency incidences and road accidents; surge in prevalence of various disorders such as cancer, respiratory diseases, and gastrointestinal disorders; upsurge in number of surgical procedures; and increased use of these in various disease diagnosis drive the inhalation anesthesia market growth. Further, there is an increase in incidence of various chronic diseases such as cancer, infectious diseases, and genetic disorders worldwide. According to the WHO, cancer is one of the leading causes of morbidity and mortality worldwide, with about 18 million cases in 2018 alone, and id expected to increase by about 70% over the next two decades. Infections known to be caused by strains of cancer are most prominent in low- and middle-income countries. In addition, factors such as innovations in these inhalation devices and governmental support regarding the use of inhalation anesthetics further fuel the market growth. However, risks associated with certain therapeutic and diagnostic devices for neonates and low adoption rate of new technologies, owing to reluctance from physicians for treatment, restrain the growth of the inhalation anesthesia devices market. In addition, environmental concerns regarding vigorous usage of inhalation anesthesia is anticipated to hamper the market growth. In addition, current trend in FDA drug approval exhibits drastic drop in pharmaceutical approvals compared to earlier authorizations, as FDA issued more rejections than typical rejections in past few years. Moreover, stringent regulations set by FDA in surgical procedures also hinder the growth of the inhalation anesthesia market. Moreover, significant rise in elderly population and increase in healthcare expenditures in developing economies are anticipated to provide lucrative growth opportunities for the market. In addition, emerging economies of Asia-Pacific and LAMEA offer lucrative growth opportunities for the expansion of inhalation anesthesia market, due to improvement in healthcare infrastructure and increase in demand for better healthcare. In addition, rise in incidences of road accidents, surgical procedures, and various diseases such as cancer and gastrointestinal disorders boost the demand for inhalation anesthesia.

Global Inhalation Anesthesia Market Segmentation

The market is segmented on the basis of product, application, end user, and region. By product it is segmented into sevoflurane, desflurane, isoflurane, and nitrous oxide. On the basis of application, it is bifurcated into induction and maintenance. By end user it is classified into hospitals and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Inhalation Anesthesia Market
By Product

Your browser does not support the canvas element.

Desflurane segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Product segment review

By product, the sevoflurane segment accounted for majority of the market share in 2018 and is expected to exhibit a prominent growth rate in the near future. This is attributed to several advantages offered by it, such as favorable blood gas solubility coefficient and pleasant odor.

Inhalation Anesthesia Market
By Application

Your browser does not support the canvas element.

Maintenance segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Application segment review

By application, the maintenance segment dominated the inhalation anesthesia market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to the increased usage of inhalation anesthesia for maintenance of general anesthesia as they enable a more specific control of the anesthetic state at a low cost.

Inhalation Anesthesia Market
By Region

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 6.0% during 2019-2026.

Get more information on this report : Request Sample Pages

Region wise, North America held the largest share in the inhalation anesthesia market in 2018, followed by Europe. The factors that drive the overall growth of the North America inhalation anesthesia market include increase in government funds for R&D of novel inhalation anesthesia as well as surge in incidences of cancer. Furthermore, rise in prevalence of diseases and surgical procedures carried out for disease treatment and development fuel the market growth. However, Asia-Pacific is anticipated to grow at the highest rate during the analysis period. This is attributed to increase in disorders, such as cancer and respiratory disorders, that often require surgery. Moreover, the market growth in this region is supplemented by increase in demand for healthcare infrastructure, rise in number of hospitals in emerging countries, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare

Comprehensive competitive analysis and profiles of major market players AbbVie Inc., Baxter International Inc., Fresenius SE & Co. KGaA., Halocarbon Products Corporation, Hikma Pharmaceuticals PLC., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd, Novartis AG, Piramal Enterprises Ltd, and Troikaa Pharmaceuticals Ltd are provided in this report.

Key Benefits for Stakeholders:

  • The inhalation anesthesia market share and analysis is based on a comprehensive analysis of key developments in the inhalation anesthesia industry.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.
  • The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.
  • The global inhalation anesthesia market trends are studied from 2018 to 2026.
  • Information about key drivers, restrains, and opportunities and their impact analysis on the market size is provided.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
  • The quantitative analysis of the global inhalation anesthesia market from 2019 to 2026 is provided to determine the market potential.

Key Market Segments:

By Product

  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide

By Application

  • Induction
  • Maintenance

By End-User

  • Hospitals
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Moderate bargaining power of buyers
3.3.2. Low bargaining power of suppliers
3.3.3. Moderate threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate competitive rivalry

3.4. Top player positioning
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Increase in number of surgeries
3.5.1.2. Surge in severe road accidents

3.5.2. Restraint

3.5.2.1. Stringent regulatory scenario

3.5.3. Opportunity

3.5.3.1. Growth opportunities in emerging economies

CHAPTER 4: INHALATION ANESTHESIA MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Sevoflurane

4.2.2. Key market trends and opportunities
4.2.3. Market size and forecast
4.2.4. Market share analysis, by country

4.3. Desflurane

4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country

4.4. Isoflurane

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country

4.5. Nitrous Oxide

4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market share analysis, by country

CHAPTER 5: INHALATION ANESTHESIA MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Induction

5.2.1. Market size and forecast
5.2.2. Market share analysis, by country

5.3. Maintenance

5.3.1. Market size and forecast
5.3.2. Market share analysis, by country

CHAPTER 6: INHALATION ANESTHESIA MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Market size and forecast
6.2.2. Market share analysis, by country

6.3. Ambulatory service centers

6.3.1. Market size and forecast
6.3.2. Market share analysis, by country

CHAPTER 7: INHALATION ANESTHESIA MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by country
7.2.3. North America market size and forecast, by product
7.2.4. North America Market size and forecast, by application
7.2.5. North America market size and forecast, by end user

7.2.5.1. U.S. market size and forecast, by product
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by product
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.8. Mexico market size and forecast, by product
7.2.5.9. Mexico market size and forecast, by application
7.2.5.10. Mexico market size and forecast, by end user

7.3. Europe

7.3.1. Key growth factors and opportunities
7.3.2. Market size and forecast, by country
7.3.3. Europe market size and forecast, by product
7.3.4. Europe Market size and forecast, by application
7.3.5. Europe market size and forecast, by end user

7.3.5.1. Germany market size and forecast, by product
7.3.5.2. Germany market size and forecast, by application
7.3.5.3. Germany market size and forecast, by end user
7.3.5.4. France market size and forecast, by product
7.3.5.5. France market size and forecast, by application
7.3.5.6. France market size and forecast, by end user
7.3.5.7. UK market size and forecast, by product
7.3.5.8. UK market size and forecast, by application
7.3.5.9. UK market size and forecast, by end user
7.3.5.10. Italy market size and forecast, by product
7.3.5.11. Italy market size and forecast, by application
7.3.5.12. Italy market size and forecast, by end user
7.3.5.13. Spain market size and forecast, by product
7.3.5.14. Spain market size and forecast, by application
7.3.5.15. Spain market size and forecast, by end user
7.3.5.17. Rest of Europe market size and forecast, by product
7.3.5.18. Rest of Europe market size and forecast, by application
7.3.5.19. Rest of Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key growth factors and opportunities.
7.4.2. Asia-Pacific market size and forecast, by country
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user

7.4.5.1. Japan market size and forecast, by product
7.4.5.2. Japan market size and forecast, by application
7.4.5.3. Japan market size and forecast, by end user
7.4.5.4. China market size and forecast, by product
7.4.5.5. China market size and forecast, by application
7.4.5.6. China market size and forecast, by end user
7.4.5.8. India market size and forecast, by product
7.4.5.9. India market size and forecast, by application
7.4.5.10. India market size and forecast, by end user
7.4.5.11. Australia market size and forecast by product
7.4.5.12. Australia market size and forecast, by application
7.4.5.13. Australia market size and forecast, by end user
7.4.5.14. Rest of Asia-Pacific market size and forecast by product
7.4.5.15. Rest of Asia-Pacific market size and forecast, by application
7.4.5.16. Rest of Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key growth factors and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user

7.5.5.1. Brazil market size and forecast, by product
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. Saudi Arabia market size and forecast, by product
7.5.5.5. Saudi Arabia market size and forecast, by application
7.5.5.6. Saudi Arabia market size and forecast, by end user
7.5.5.7. South Africa market size and forecast, by product
7.5.5.8. South Africa market size and forecast, by application
7.5.5.9. South Africa market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by product
7.5.5.11. Rest of LAMEA market size and forecast, by application
7.5.5.12. Rest of LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. ABBVIE INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segment
8.1.4. Product portfolio
8.1.5. Business performance

8.2. BAXTER INTERNATIONAL INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance

8.3. Fresenius SE & Co. KGaA

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio

8.3.5. Business performance

8.4. Halocarbon Products Corporation.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio

8.5. Hikma Pharmaceuticals PLC

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance

8.6. Jiangsu Hengrui Medicine Co., Ltd.

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Product portfolio

8.7. Lunan Pharmaceutical Group Co. Ltd.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio

8.8. Novartis AG.

8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Product portfolio
8.8.4. Business performance
8.8.5. Key strategic moves and developments

8.9. Piramal Enterprises Ltd.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. Troikaa Pharmaceuticals, Ltd.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio

LIST OF TABLES

TABLE 01. INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. INHALATION ANESTHESIA MARKET FOR SEVOFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 03. INHALATION ANESTHESIA MARKET FOR DESFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 04. INHALATION ANESTHESIA MARKET FOR ISOFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 05. INHALATION ANESTHESIA MARKET FOR NITROUS OXIDE, BY REGION, 2018–2026 ($MILLION)
TABLE 06. INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 07. INHALATION ANESTHESIA MARKET FOR INDUCTION, BY REGION, 2018–2026 ($MILLION)
TABLE 08. INHALATION ANESTHESIA FOR MAINTENANCES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 10. INHALATION ANESTHESIA MARKET FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. INHALATION ANESTHESIA MAINTENANCES MARKET FOR AMBULATORY SERVICE CENTERS, BY REGION, 2018–2026 ($MILLION)
TABLE 12. INHALATION ANESTHESIA MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 16. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 17. U.S. INHALATION ANESTHESIA MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 18. U.S. INHALATION ANESTHESIA MARKET BY APPLICATION, 2018–2026 ($MILLION)
TABLE 19. U.S. INHALATION ANESTHESIA MARKET BY END USER, 2018–2026 ($MILLION)
TABLE 20. CANADA INHALATION ANESTHESIA MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 21. CANADA INHALATION ANESTHESIA MARKET BY APPLICATION, 2018–2026 ($MILLION)
TABLE 22. CANADA INHALATION ANESTHESIA MARKET BY END USER, 2018–2026 ($MILLION)
TABLE 23. MEXICO INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 24. MEXICO INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 25. MEXICO INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. EUROPE INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 27. EUROPE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 28. EUROPE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 29. EUROPE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. GERMANY INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 31. GERMANY INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32. GERMANY INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 33. FRANCE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 34. FRANCE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 35. FRANCE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. U.K. INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 37. U.K. INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 38. U.K. INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 39. ITALY INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 40. ITALY INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 41. ITALY INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 42. SPAIN INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 43. SPAIN INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 44. SPAIN INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 46. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 47. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 48. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 49. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 50. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION),
TABLE 51. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 52. JAPAN INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 53. JAPAN INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54. JAPAN INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 55. CHINA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 56. CHINA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 57. CHINA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58. INDIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 59. INDIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 60. INDIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 61. AUSTRALIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 62. AUSTRALIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 63. AUSTRALIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 67. LAMEA INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 68. LAMEA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 69. LAMEA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION),
TABLE 70. LAMEA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 71. BRAZIL INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 72. BRAZIL INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 73. BRAZIL INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 74. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 75. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 76. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 77. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 78. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 79. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 80. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 81. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 82. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 83. ABBVIE: COMPANY SNAPSHOT
TABLE 84. ABBVIE: OPERATING BUSINESS SEGMENT
TABLE 85. ABBVIE: PRODUCT PORTFOLIO
TABLE 86. BAXTER: COMPANY SNAPSHOT
TABLE 87. BAXTER: BUSINESS UNITS
TABLE 88. FRESENIUS: COMPANY SNAPSHOT
TABLE 89. FRESENIUS: OPERATING BUSINESS SEGMENTS
TABLE 90. FRESENIUS: PRODUCT PORTFOLIO
TABLE 91. HALOCARBONS: COMPANY SNAPSHOT
TABLE 92. HALOCARBONS: PRODUCT BUSINESS SEGMENT
TABLE 93. HALOCARBONS: PRODUCT PORTFOLIO
TABLE 94. HIKIMA: COMPANY SNAPSHOT
TABLE 95. HIKIMA: OPERATING SEGMENTS
TABLE 96. HIKIMA: PRODUCT PORTFOLIO
TABLE 97. HENGRUI.: COMPANY SNAPSHOT
TABLE 98. HENGRUI.: OPERATING BUSINESS SEGMENTS
TABLE 99. HENGRUI.: PRODUCT PORTFOLIO
TABLE 100. LUNAN: COMPANY SNAPSHOT
TABLE 101. LUNAN: PRODUCT PORTFOLIO
TABLE 102. NOVARTIS: COMPANY SNAPSHOT
TABLE 103. NOVARTIS: OPERATING BUSINESS SEGMENTS
TABLE 104. NOVARTIS: PRODUCT PORTFOLIO
TABLE 105. PIRAMAL: COMPANY SNAPSHOT
TABLE 106. PIRAMAL: OPERATING SEGMENTS
TABLE 107. PIRAMAL: PRODUCT PORTFOLIO
TABLE 108. TROIKAA: COMPANY SNAPSHOT
TABLE 109. TROIKAA: OPERATING SEGMENTS
TABLE 110. TROIKAA: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. INHALATION ANESTHESIA, MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING
FIGURE 04. DRIVERS, RESTRAINT, AND OPPORTUNITY, INHALATION ANESTHESIA MARKET
FIGURE 05. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR SEVOFLURANE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 06. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR DESFLURANE MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR ISOFLURANE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR NITROUS OXIDE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR INDUCTION, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR MAINTENANCE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF AMBULATORY SERVICE CENTERS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. ABBVIE: NET SALES, 2016–2018 ($MILLION)
FIGURE 14. ABBVIE: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 15. NET SALES, 2016–2018 ($MILLION)
FIGURE 16. BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2018 (%)
FIGURE 17. BAXTER: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 18. FRESENIUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 19. FRESENIUS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 20. FRESENIUS: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 21. HIKIMA: NET SALES, 2016–2018 ($MILLION)
FIGURE 22. HIKIMA: REVENUE SHARE BY SEGMNET, 2018 (%)
FIGURE 23. HIKIMA: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 24. NOVARTIS AG: NET SALES, 2016–2018 ($MILLION)
FIGURE 25. NOVARTIS AG: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 26. NOVARTIS AG: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 27. PIRAMAL: NET SALES, 2016–2019 ($MILLION)
FIGURE 28. PIRAMAL: REVENUE SHARE BY SEGMENT, 2019 (%)

 
 

Inhalational anesthesia is a chemical compound compromising general anesthetic properties that can be delivered via inhalation. The inhalation anesthesia market is expected to witness a significant growth in the future as it has gained the interest of the healthcare industry, owing to increase in prevalence of various disorders and surgical procedures globally.

The inhalation anesthetics is an established technology; hence, is expected to experience an increase in adoption rate. In addition, technological advancements are prevalent in the market, thus there is rise in the number of product launches, due to which the market is estimated to grow with a high growth rate. Furthermore, increase in demand for quality healthcare products around the globe is expected to drive the market growth. Technological advancements and prevalence of diseases, such as cancer, fuel the growth of the market. Key market players are continuously focusing toward new product development to provide surgical assistance to surgeons and doctors for prolonged sophisticated surgical procedures. North America accounts for the maximum market share, owing to the highest adoption of inhalation anesthetics in the region, which is expected to follow the same trend during the forecast period. However, Asia-Pacific is anticipated to grow at the fastest growth rate during the forecast period, owing to considerable increase in the number of hospitals and surgical procedures.  

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, Subscription @ $699 T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The market vaule of global Inhalation Anesthesias market was $1,137 million in 2018.

A. The forecast period is from 2019 to 2026.

A. The market value of global Inhalation Anesthesia market in 2019 is $1,160 million.

A. The adoption of Inhalation Anesthesia is expected to increase due to rise in various surgical processes and surge in road accident incidences.

A. No, the report does not provides value chain analysis.

A. Introduction of various compunds that possess lesser side effects.

A. Emerging countries of Asia-Pacific region are growing at a growth rate of 6.0%. China, Australia, are expected grow at a CAGR of 6.6% and 6.3% respectively.

A. The North America market held a major share in the Inhalation Anesthesias market in 2018 and is expected to continue the trend in the forecasting period.

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Inhalation Anesthesia Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $4,904
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,160
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $6,746
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $0.00
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts